ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
نویسندگان
چکیده
منابع مشابه
Shenqi Fuzheng Injection Combined with Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
Purpose. To evaluate the therapeutic effectiveness and safety of shenqi fuzheng injection (SFI) in the associated chemotherapy of breast cancer. Methods. 1247 subjects were included in this study for meta-analysis with RevMan 5.3. Results. The clinical curative effective rate (OR = 2.03, 95% Cl [1.44, 2.86], P < 0.0001), grades of KPS (OR = 4.11, 95% Cl [2.74, 6.16], P < 0.00001), CD3(+) cells ...
متن کاملShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
OBJECTIVE This study aims to investigate cellular immunity and clinical efficacy of ShenQi FuZheng Injection (SFI) in the associated chemotherapy of colorectal cancer (CRC). METHODS PubMed, Cochrane Library, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), WanFang Database and Chinese Biomedical Literature Database (CBM) searches we...
متن کاملImmunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis
Background. Immunosuppression is a well-recognised complication of chemotherapy in cancer patients. We assemble the clinical evidence that SQI, an adjuvant drug for lung cancer and gastric cancer which was widely prescribed in China, interventions could increase objective tumour response and regulate immunity in cancer patients undergoing chemotherapy. Methods. We undertook a systemic review of...
متن کامل[Clinical study on treatment of malignant neoplasms with Shenqi Fuzheng Injection and chemotherapy].
1 .1 纳入标准 (1)年龄 < 70 岁;(2)Karnofsky 活 动状况(Karnofs ky performance status, K PS)评分 > 60; (3)预计生存期 > 6 个月; (4)无化疗禁忌 症 ;(5)知情同意,依从性好,能连续完成 2 个疗程 的化疗。 1 .2 一般资料 2002 年 12 月~2004 年 5 月在我 院住院治疗且符合纳入标准的病理诊断明确的恶性 肿瘤患者,共 86 例,其中男 46 例,女 40 例;年龄 26~69 岁,平均 53 岁;其中肺癌 26 例, 大肠癌 22 例,鼻咽癌 16 例,乳腺癌 12 例,卵巢癌 6 例,恶 性淋巴瘤 4 例。 1 .3 病例分组 采用随机交叉试验设计,86 例患 者随机分为 A、B 两组。A 组 43 例,第 1 周期(对照 周期)给予化疗 1 个疗程,间歇 3~4 周,第 2 周期...
متن کاملReview Article Chinese Herbal Medicine as Adjunctive Therapy to Chemotherapy for Breast Cancer: A Systematic Review and Meta-Analysis
1Department of Oncology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing 100010, China 2Beijing University of Chinese Medicine, Beijing 100029, China 3Department of Oncology, Third Affiliated Hospital of Henan College of Traditional Chinese Medicine, Zhengzhou 450000, China 4Department of Medical Biochemistry and Microbiology, Uppsala University, 75123 Upps...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutical Biology
سال: 2019
ISSN: 1388-0209,1744-5116
DOI: 10.1080/13880209.2019.1660383